Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
Trastuzumab-MMAE-DXd
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $2,080 | - | In Stock |
| Description | Trastuzumab-MMAE-DXd is an antibody-drug conjugate in which Trastuzumab is conjugated to MMAE as the payload. Trastuzumab is a humanized monoclonal antibody that selectively binds HER2 with high affinity. Trastuzumab has been utilized in research involving HER2-positive metastatic breast cancer and gastric cancer. Trastuzumab-MMAE-DXd serves as a valuable research construct for investigating HER2-targeted delivery systems, antibody-drug conjugate design, and HER2-associated tumor biology. |
| Reactivity | Human |
| Application | Functional assay |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Antibody: Trastuzumab (T9912) Linker: Not confirmed Payload: MMAE; DXd |
| Gene ID | |
| Uniprot ID | |
| Target | HER2/ERBB2 |
| Isotype | Human IgG1 kappa-MMAE-DXd |
| Storage | Store at low temperature, -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.